Effects of chemical myosin II cross‐bridge inhibitors on eccentric force production in skinned muscle fibres
Experimental Physiology · 2026-07 · 111 (7) · 3337-3356
DOI: 10.1113/ep093831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 01.06.2026. Verfasst von André Tomalka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Motion and Exercise Science, University of Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Muscle Contraction, Myosin Type II, Muscle Fibers, Skeletal. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Eccentric muscle contractions are essential for locomotion and daily activities. Force during these contractions depends on both cross‐bridge (XB) and non‐cross‐bridge (non‐XB) elements, including titin, with contributions varying by fibre type and contraction velocity. Despite their importance, mechanisms of force generation during prolonged stretches remain unclear. Chemical XB inhibitors are commonly used to separate XB and non‐XB contributions, but their effects have not been systematically compared under identical conditions. We measured eccentric force in single permeabilised fibres from fast‐twitch rat extensor digitorum longus (EDL) and slow‐twitch soleus (SOL) muscles. Fibres were treated with blebbistatin (Bleb), 2,3‐butanedione monoxime (BDM), or N ‐benzyl‐ p ‐toluene sulphonamide (BTS) and stretched from 0.85 to 1.3 times optimal length at three velocities (0.01, 0.1 and 1.0 maximal contraction velocity). XB inhibition produced fibre‐type‐dependent effects on early‐ and late‐stretch force (slope 1 , slope 2 ) and on end‐of‐stretch force ( s e ). Stretch velocity and the type of XB inhibitor influenced s e in both SOL and EDL fibres. However, in EDL fibres, s e did not differ significantly between XB inhibitors and showed velocity‐dependent effects under Bleb and BTS only, but not under BDM. Stretch‐induced forces were less reduced than isometric forces, indicating substantial stretch‐dependent non‐XB contributions. These results show that eccentric force arises from coordinated XB and non‐XB mechanisms in a fibre‐type‐dependent manner and highlight Bleb as an effective tool for probing these contributions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Motion and Exercise Science, University of Stuttgart, Stuttgart, Germany.
- Institute of Sport Science, Department of Biomechanics, University of Rostock, Rostock, Germany.
- Stuttgart Center for Simulation Science, University of Stuttgart, Stuttgart, Germany.
ORCID-Profile: André Tomalka
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Tomalka, A., Weidner, S., Rode, C., & Siebert, T. (2026). Effects of chemical myosin II cross‐bridge inhibitors on eccentric force production in skinned muscle fibres. Experimental Physiology, 111(7), 3337-3356. https://doi.org/10.1113/ep093831
Vancouver
Tomalka A, Weidner S, Rode C, Siebert T. Effects of chemical myosin II cross‐bridge inhibitors on eccentric force production in skinned muscle fibres. Experimental Physiology. 2026;111(7):3337-3356. doi:10.1113/ep093831
BibTeX
@article{Tomalka2026,
author = {Tomalka, André and Weidner, Sven and Rode, Christian and Siebert, Tobias},
title = {Effects of chemical myosin II cross‐bridge inhibitors on eccentric force production in skinned muscle fibres},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {7},
pages = {3337--3356},
doi = {10.1113/ep093831}
}
EUVIMED